DE60042776D1 - Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen - Google Patents

Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen

Info

Publication number
DE60042776D1
DE60042776D1 DE60042776T DE60042776T DE60042776D1 DE 60042776 D1 DE60042776 D1 DE 60042776D1 DE 60042776 T DE60042776 T DE 60042776T DE 60042776 T DE60042776 T DE 60042776T DE 60042776 D1 DE60042776 D1 DE 60042776D1
Authority
DE
Germany
Prior art keywords
lipoglykan
compositions
treatment
methods
parasitic infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60042776T
Other languages
English (en)
Inventor
Lloyd H Semprevivo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Massachusetts UMass
Original Assignee
University of Massachusetts UMass
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Massachusetts UMass filed Critical University of Massachusetts UMass
Application granted granted Critical
Publication of DE60042776D1 publication Critical patent/DE60042776D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DE60042776T 1999-03-12 2000-03-10 Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen Expired - Fee Related DE60042776D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12
PCT/US2000/006404 WO2000053220A1 (en) 1999-03-12 2000-03-10 Lipoglycan compositions and methods of treating parasitic infections

Publications (1)

Publication Number Publication Date
DE60042776D1 true DE60042776D1 (de) 2009-10-01

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042776T Expired - Fee Related DE60042776D1 (de) 1999-03-12 2000-03-10 Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen

Country Status (17)

Country Link
US (3) US6428793B1 (de)
EP (1) EP1175226B1 (de)
JP (1) JP2002538220A (de)
AT (1) ATE439857T1 (de)
AU (1) AU771373B2 (de)
BR (1) BR0008949A (de)
CA (1) CA2364507A1 (de)
DE (1) DE60042776D1 (de)
HU (1) HUP0200466A3 (de)
MA (1) MA25347A1 (de)
MX (1) MXPA01009206A (de)
NO (1) NO20014411L (de)
NZ (1) NZ514112A (de)
PL (1) PL203789B1 (de)
TR (3) TR200103231T2 (de)
WO (1) WO2000053220A1 (de)
ZA (1) ZA200107502B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
EP2494980A3 (de) * 2009-10-21 2013-03-13 ETH Zurich Medizinische Nützlichkeit von Glycanen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
US6261788B1 (en) * 1998-09-21 2001-07-17 The Board Of Regents Of The University Of Oklahoma Diagnostic assays for infectious parasitic helminths

Also Published As

Publication number Publication date
HUP0200466A2 (en) 2002-06-29
HUP0200466A3 (en) 2006-11-28
US7063848B2 (en) 2006-06-20
US20060228382A1 (en) 2006-10-12
TR200202066T2 (tr) 2004-12-21
TR200202078T2 (tr) 2002-11-21
US7204983B2 (en) 2007-04-17
WO2000053220A1 (en) 2000-09-14
TR200103231T2 (tr) 2002-03-21
MA25347A1 (fr) 2001-12-31
AU3625100A (en) 2000-09-28
ZA200107502B (en) 2003-02-26
NO20014411D0 (no) 2001-09-11
EP1175226A1 (de) 2002-01-30
NZ514112A (en) 2003-08-29
PL350989A1 (en) 2003-02-24
NO20014411L (no) 2001-11-09
CA2364507A1 (en) 2000-09-14
US20020160021A1 (en) 2002-10-31
JP2002538220A (ja) 2002-11-12
EP1175226A4 (de) 2005-01-05
ATE439857T1 (de) 2009-09-15
US6428793B1 (en) 2002-08-06
BR0008949A (pt) 2002-09-24
MXPA01009206A (es) 2003-07-14
AU771373B2 (en) 2004-03-18
PL203789B1 (pl) 2009-11-30
EP1175226B1 (de) 2009-08-19

Similar Documents

Publication Publication Date Title
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
ATE192153T1 (de) Amino-imidazo (4,5-c) chinoline
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
FI955389A0 (fi) Tandskyddande profylaktisk preparat och administreringsmedlen emot mellanoerpatogener
ATE195740T1 (de) Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
DE69733611D1 (de) Verfahren und potenzierte zusammensetzung zur behandlung von migräne
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
NO20045240L (no) Transepikutan administrasjonsform for a behandle restless legs syndromet
DK1299130T3 (da) Fremgangsmåde til behandling og forebyggelse af smitsomme sygdomme
PT692028E (pt) Farmacos baseados em papilomavirus
BG101937A (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors
FI972703A (fi) Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia
EE9900428A (et) Köhavastased ravimkoostised
DE60331725D1 (de) Therapeutische mittel als antikrebs impfstoffadjuvantien und deren therapeutische verfahren
DE60042776D1 (de) Lipoglykan zusammensetzungen und methoden zur behandlung von parasitischen infektionen
WO2001039765A3 (en) Compositions and methods for the induction and treatment of retinal detachments
WO2000057908A3 (en) Attenuated dengue-1 virus vaccine
EA199700150A1 (ru) КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC
EP1131338A4 (de) Methode für die herstellung von gereinigtem invasinprotein und seine anwendung
NO992030L (no) Terapeutiske og kosmetiske sammensetninger, deres anvendelse og fremgangsmÕte for fremstilling derav
WO2003006645A3 (en) Method and composition for inhibiting heparanase activity

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee